15.49
0.13%
0.02
After Hours:
15.50
0.010
+0.06%
Medifast Inc stock is traded at $15.49, with a volume of 155.72K.
It is up +0.13% in the last 24 hours and down -6.57% over the past month.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
See More
Previous Close:
$15.47
Open:
$15.58
24h Volume:
155.72K
Relative Volume:
0.70
Market Cap:
$169.43M
Revenue:
$1.07B
Net Income/Loss:
$99.41M
P/E Ratio:
1.7097
EPS:
9.06
Net Cash Flow:
$141.17M
1W Performance:
-1.78%
1M Performance:
-6.57%
6M Performance:
-23.58%
1Y Performance:
-71.25%
Medifast Inc Stock (MED) Company Profile
Name
Medifast Inc
Sector
Industry
Phone
(732) 764-0619
Address
11445 CRONHILL DRIVE, OWINGS MILLS, MD
Compare MED with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
MED
Medifast Inc
|
15.49 | 169.43M | 1.07B | 99.41M | 141.17M | 9.06 |
ROL
Rollins Inc
|
50.26 | 24.34B | 3.31B | 469.51M | 537.75M | 0.96 |
SCI
Service Corp International
|
76.87 | 11.12B | 4.15B | 505.69M | 587.50M | 3.44 |
HRB
H R Block Inc
|
54.20 | 7.56B | 3.62B | 586.22M | 657.77M | 4.10 |
BFAM
Bright Horizons Family Solutions Inc
|
121.81 | 7.09B | 2.63B | 116.59M | 215.93M | 1.99 |
FTDR
Frontdoor Inc
|
59.58 | 4.52B | 1.83B | 234.00M | 235.00M | 3.03 |
Medifast Inc Stock (MED) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-05-24 | Upgrade | DA Davidson | Underperform → Neutral |
Jun-05-24 | Downgrade | DA Davidson | Neutral → Underperform |
Oct-13-23 | Initiated | Stephens | Equal-Weight |
Nov-04-22 | Downgrade | DA Davidson | Buy → Neutral |
Aug-04-22 | Downgrade | Jefferies | Buy → Hold |
Jan-25-21 | Upgrade | Jefferies | Hold → Buy |
Nov-05-20 | Upgrade | DA Davidson | Neutral → Buy |
Jun-25-20 | Initiated | B. Riley FBR | Buy |
Feb-27-20 | Downgrade | Jefferies | Buy → Hold |
Nov-08-19 | Downgrade | Dougherty & Company | Buy → Neutral |
Jul-25-19 | Initiated | Jefferies | Buy |
Nov-08-18 | Upgrade | Sidoti | Neutral → Buy |
Mar-07-18 | Upgrade | Sidoti | Neutral → Buy |
Sep-15-17 | Reiterated | DA Davidson | Buy |
Aug-04-16 | Reiterated | Wunderlich | Hold |
Jan-11-16 | Upgrade | Sidoti | Neutral → Buy |
Nov-30-15 | Downgrade | Sidoti | Buy → Neutral |
Oct-05-15 | Upgrade | Sidoti | Neutral → Buy |
Nov-07-14 | Downgrade | Imperial Capital | Outperform → In-line |
Aug-08-14 | Reiterated | Imperial Capital | Outperform |
Apr-23-14 | Reiterated | Imperial Capital | Outperform |
Sep-06-13 | Initiated | Imperial Capital | Outperform |
Nov-06-12 | Reiterated | Northland Securities | Outperform |
Jul-27-12 | Upgrade | Northland Securities | Market Perform → Outperform |
Jul-09-12 | Downgrade | Standpoint Research | Buy → Hold |
Jan-30-12 | Initiated | Standpoint Research | Buy |
View All
Medifast Inc Stock (MED) Latest News
Medifast Earnings Alert: Key Financial Results Coming February 18What's at Stake for OPTAVIA - StockTitan
JPMorgan Chase & Co. Increases Position in Medifast, Inc. (NYSE:MED) - MarketBeat
MED Focused on GLP-1 Solutions Amid Customer Acquisition Challenges - MSN
Medifast: Strong Balance Sheet, But I Lack Conviction In The Turnaround (NYSE:MED) - Seeking Alpha
Medifast stock hits 52-week low at $15.09 amid sharp decline - MSN
Weight Loss Diet Products Market Projected To Witness Substantial Growth, 2024-2031|VLCC Healthcare Ltd, - EIN News
Medifast Launches OPTAVIA ASCEND for Weight Loss Management - MSN
An Intrinsic Calculation For Medifast, Inc. (NYSE:MED) Suggests It's 41% Undervalued - Simply Wall St
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off - Marketscreener.com
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off – Company AnnouncementFT.com - Financial Times
Medifast Launches OPTAVIA ASCEND: High-Protein Line Targets GLP-1 Weight Management Challenge - StockTitan
Medifast stock hits 52-week low at $16.7 amid sharp decline - Investing.com Nigeria
Medifast, Inc. (NYSE:MED) Stock Holdings Decreased by Geode Capital Management LLC - MarketBeat
Dan Chard - Maryland Daily Record
Medifast Announces Global Expansion with its Lifestyle Brand, OPTAVIA® - Marketscreener.com
Jane Street Group LLC Reduces Holdings in Medifast, Inc. (NYSE:MED) - MarketBeat
Medifast stock hits 52-week low at $17.05 amid sharp decline - Investing.com Canada
Medifast stock hits 52-week low at $17.05 amid sharp decline By Investing.com - Investing.com South Africa
Is Medifast, Inc.'s (NYSE:MED) Stock Price Struggling As A Result Of Its Mixed Financials? - Yahoo Finance
Charles Schwab Investment Management Inc. Trims Position in Medifast, Inc. (NYSE:MED) - Defense World
Charles Schwab Investment Management Inc. Sells 27,336 Shares of Medifast, Inc. (NYSE:MED) - MarketBeat
Medifast, Inc.'s (NYSE:MED) Business And Shares Still Trailing The Industry - Simply Wall St
Hotchkis & Wiley Capital Management LLC Sells 28,000 Shares of Medifast, Inc. (NYSE:MED) - MarketBeat
Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications - Yahoo Finance
Medifast (MED) Down 5.8% Since Last Earnings Report: Can It Rebound? - MSN
Do Options Traders Know Something About Medifast (MED) Stock We Don't? - MSN
Cloudflare Inc Cl A (NET-N) QuotePress Release - The Globe and Mail
Three Reasons to Avoid MED and One Stock to Buy Instead - Yahoo Finance
Medifast to Pay SEC Penalty of $200,000 Over Financial Restatements - AOL
Best High Yield Dividend Stocks (October 2024) - Investing.com
Brokers Issue Forecasts for Medifast FY2024 Earnings - MarketBeat
Research Analysts Set Expectations for Medifast Q2 Earnings - MarketBeat
MED (Medifast) Cyclically Adjusted PS Ratio : 0.24 (As of Nov. 26, 2024) - GuruFocus.com
How Should You Play Medifast Stock at a P/E Multiple of 17.6X? - MSN
Plant-based Beverage Market is Estimated to Reach $56.73 Billion with a 11.9% CAGR By 2034 | Fact.MR Reports - GlobeNewswire Inc.
Medifast Inc Stock (MED) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):